Literature DB >> 3887349

A clinical comparison of purified bovine and purified porcine insulins.

S A Olczak, R H Greenwood.   

Abstract

Twenty four patients with established insulin dependent diabetes treated with twice daily soluble and isophane bovine insulins were changed to equivalent doses of either purified bovine Neusulin and Neuphane (Wellcome) or purified porcine Actrapid and Monotard (Novo) insulins. After 6 months treatment the porcine group showed a 35% fall in insulin binding antibodies and a 14% reduction in insulin dosage. The group changed to purified bovine insulins showed no significant change in insulin binding antibodies and no change in insulin dose. Mean blood glucose and glycosylated serum protein fell in both groups during the study period but there was no significant difference between the two groups.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887349      PMCID: PMC2418120          DOI: 10.1136/pgmj.61.711.15

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  The clinical significance of insulin antibodies.

Authors:  O O Andersen; J Egeberg
Journal:  Acta Paediatr Scand Suppl       Date:  1977

2.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

3.  Insulin antibodies and the control of diabetes.

Authors:  K Dixon; P D Exon; J M Malins
Journal:  Q J Med       Date:  1975-10

4.  Anti-insulin-antibodies and late diabetic complications.

Authors:  O O Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

5.  Association of specific immune response to pork and beef insulin with certain HLA-DR antigens in type 1 diabetes.

Authors:  I Sklenar; T M Neri; W Berger; P Erb
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-20

6.  [The antigenicity of various new chromatographically purified depot insulin preparations].

Authors:  D Graber; S Fankhauser
Journal:  Schweiz Med Wochenschr       Date:  1978-11-18

7.  Effects of species of origin, purification levels, and formulation on insulin immunogenicity.

Authors:  S E Fineberg; J A Galloway; N S Fineberg; J Goldman
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

8.  C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.

Authors:  D K Yue; R C Baxter; J R Turtle
Journal:  Metabolism       Date:  1978-01       Impact factor: 8.694

9.  The effect of insulin antibodies on insulin dose and diabetic control.

Authors:  S Walford; S P Allison; W G Reeves
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

10.  Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

Authors:  W G Reeves; B R Allen; R B Tattersall
Journal:  Br Med J       Date:  1980-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.